These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38857659)

  • 1. A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions.
    Tondi Resta I; Rind A; Montone KT; Livolsi VA; Baloch ZW
    Hum Pathol; 2024 Jul; 149():29-38. PubMed ID: 38857659
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
    Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine-needle aspiration cytomorphology of papillary thyroid carcinoma with NTRK gene rearrangement from a case series with predominantly indeterminate cytology.
    Abi-Raad R; Prasad ML; Adeniran AJ; Cai G
    Cancer Cytopathol; 2020 Nov; 128(11):803-811. PubMed ID: 32931153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytomorphologic features of NTRK-rearranged thyroid carcinoma.
    Viswanathan K; Chu YH; Faquin WC; Sadow PM
    Cancer Cytopathol; 2020 Nov; 128(11):812-827. PubMed ID: 33074583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Prasad ML; Vyas M; Horne MJ; Virk RK; Morotti R; Liu Z; Tallini G; Nikiforova MN; Christison-Lagay ER; Udelsman R; Dinauer CA; Nikiforov YE
    Cancer; 2016 Apr; 122(7):1097-107. PubMed ID: 26784937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NTRK fusion analysis reveals enrichment in Middle Eastern BRAF wild-type PTC.
    Kong Y; Bu R; Parvathareddy SK; Siraj AK; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
    Eur J Endocrinol; 2021 Apr; 184(4):503-511. PubMed ID: 33524004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic and molecular characterization of NTRK-rearranged thyroid carcinoma (NRTC).
    Chu YH; Dias-Santagata D; Farahani AA; Boyraz B; Faquin WC; Nosé V; Sadow PM
    Mod Pathol; 2020 Nov; 33(11):2186-2197. PubMed ID: 32457407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of neurotrophic tropomyosin receptor kinase (NTRK) fusion gene positivity in patients with solid tumors in Japan.
    Nakata E; Osone T; Ogawa T; Taguchi T; Hattori K; Kohsaka S
    Cancer Med; 2024 Jun; 13(12):e7351. PubMed ID: 38925616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular characterization of cancers with NTRK gene fusions.
    Gatalica Z; Xiu J; Swensen J; Vranic S
    Mod Pathol; 2019 Jan; 32(1):147-153. PubMed ID: 30171197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pan-Trk Immunohistochemistry Is an Efficient and Reliable Screen for the Detection of NTRK Fusions.
    Hechtman JF; Benayed R; Hyman DM; Drilon A; Zehir A; Frosina D; Arcila ME; Dogan S; Klimstra DS; Ladanyi M; Jungbluth AA
    Am J Surg Pathol; 2017 Nov; 41(11):1547-1551. PubMed ID: 28719467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
    Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
    Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NTRK Fusion in a Cohort of BRAF p. V600E Wild-Type Papillary Thyroid Carcinomas.
    Lee SE; Lee MS; Bang H; Kim MY; Choi YL; Oh YL
    Mod Pathol; 2023 Aug; 36(8):100180. PubMed ID: 37003481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How Sensitive is Pan-TRK Immunohistochemistry for Detecting NTRK Fusions in Papillary Thyroid Carcinoma?
    Hang JF; Lee YC
    Mod Pathol; 2023 Jul; 36(7):100222. PubMed ID: 37336120
    [No Abstract]   [Full Text] [Related]  

  • 14. Indeterminate Thyroid Fine-Needle Aspirations in Pediatrics: Exploring Clinicopathologic Features and Utility of Molecular Profiling.
    Baran JA; Halada S; Bauer AJ; Ricarte-Filho JC; Isaza A; Surrey LF; McGrath C; Bhatti T; Jalaly J; Mostoufi-Moab S; Franco AT; Adzick NS; Kazahaya K; Cahill AM; Baloch Z
    Horm Res Paediatr; 2022; 95(5):430-441. PubMed ID: 35871517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of NTRK gene fusions in lung adenocarcinomas in the Chinese population.
    Zhao R; Yao F; Xiang C; Zhao J; Shang Z; Guo L; Ding W; Ma S; Yu A; Shao J; Zhu L; Han Y
    J Pathol Clin Res; 2021 Jul; 7(4):375-384. PubMed ID: 33768710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of NTRK1/3 Rearrangements in Papillary Thyroid Carcinoma Using Immunohistochemistry, Fluorescent In Situ Hybridization, and Next-Generation Sequencing.
    Lee YC; Chen JY; Huang CJ; Chen HS; Yang AH; Hang JF
    Endocr Pathol; 2020 Dec; 31(4):348-358. PubMed ID: 32880785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. THADA-IGF2BP3 gene fusions in thyroid fine needle aspiration is involved in the pathway to "noninvasive follicular thyroid neoplasm with papillary-like nuclear features".
    Zand A; Kim TH; Rodriguez EF; Moatamed NA
    Diagn Cytopathol; 2024 Nov; 52(11):627-632. PubMed ID: 38877784
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bastos AU; de Jesus AC; Cerutti JM
    Eur J Endocrinol; 2018 Jan; 178(1):83-91. PubMed ID: 29046324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotrophic tyrosine receptor kinase gene fusions in adult and pediatric patients with solid tumors: a clinicogenomic biobank and record linkage study of expression frequency and patient characteristics from Finland.
    Zhang W; Schmitz AA; Kallionpää RE; Perälä M; Pitkänen N; Tukiainen M; Alanne E; Jöhrens K; Schulze-Rath R; Farahmand B; Zong J
    Acta Oncol; 2024 Jul; 63():542-551. PubMed ID: 38967220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological analysis of thyroid carcinomas with the RET and NTRK fusion genes: characterization for genetic analysis.
    Okubo Y; Toda S; Kadoya M; Sato S; Yoshioka E; Hasegawa C; Ono K; Washimi K; Yokose T; Miyagi Y; Masudo K; Iwasaki H; Hayashi H
    Virchows Arch; 2024 Sep; 485(3):509-518. PubMed ID: 38472412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.